The Lockwood Group

What The Lockwood Group does

The Lockwood Group is a privately held, Ares Management-owned healthcare services platform headquartered in Stamford, Connecticut, operating through a network of seven wholly owned subsidiaries: Lockwood Medical Communications (core medcomms agency), Random42 (London-based scientific animation and XR studio), Nexus Health (market access consulting), IDEOlogy Health (omnichannel medical education), Research To Practice (oncology and hematology continuing medical education), Total Health (live and virtual oncology conferences), and Stratis Group (commercialization analytics). Founded in 2007, the company employs more than 800 professionals, including over 150 PhDs, MDs, and experienced medical writers covering 100+ disease states, and reports operational scale including 150+ product launches, support for 100+ oncology brands, and 300+ hours of accredited oncology education content.

The company serves three primary customer segments: pharmaceutical, biotechnology, and medical device companies that purchase strategic medical communications, publications, medical affairs, market access, and scientific visualization services on a project-quote basis; oncology and hematology healthcare professionals who receive free accredited CME/NCPD education through RTP and Total Health; and rare disease companies served through a specialized Lockwood Rare Disease sub-brand. Revenue is generated entirely through professional services engagements (no disclosed self-serve or productized pricing), with educational content distributed freemium to clinicians to build engagement reach that, in turn, supports paid pharma-sponsored programs and KOL engagement.

Technology underpins service delivery rather than being sold standalone. The proprietary Lockwood Intelligence platform applies AI-enabled capabilities to content enhancement, literature review, HCP engagement intelligence, and congress coverage; the AIMED Method uses non-generative AI for visual performance optimization of medical posters and slides; and the SiMPL Method supports health literacy improvements in patient materials. Distribution combines direct enterprise sales teams serving pharma/biotech accounts with self-serve digital education platforms and 60+ live and virtual programs annually. The company's growth strategy has been predominantly inorganic, with five completed acquisitions since 2022 accelerating capability expansion across medical education, market access, and scientific animation.

Name

The Lockwood Group

Legal name

The Lockwood Group

Website

https://thelockwoodgrp.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The Lockwood Group is a private, Ares Management-owned healthcare services platform operating through seven subsidiaries that deliver medical communications, accredited oncology education, scientific animation, and market access consulting to pharmaceutical, biotechnology, and medical device clients.

Ownership category

akta.pro rank

Product category

Healthcare Services / Medical Communications

NAICS

Other Scientific and Technical Consulting Services (54169), Management Consulting Services (54161)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

akta.pro secondary industry

Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL)

Keywords

• Medical communications services
• Scientific animation visualization
• Medical affairs consulting
• Oncology medical education
• Market access strategy

Headquarters

HQ city

Stamford

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Medical Communications Services: Professional services revenue from medical affairs, publications, and commercial marketing services for pharmaceutical and biotech clients. Services include strategic consulting, content development, KOL engagement, and regulatory support.
2. Medical Education Services: Accredited continuing medical education (CME) and professional education programs for healthcare providers in oncology and hematology. Delivered through live symposia, virtual events, digital content, and conferences.
3. Scientific Animation and Visualization: Custom scientific animation, extended reality (XR), and interactive experiences for pharmaceutical companies to communicate complex scientific concepts and drug mechanisms.
4. Market Access Consulting: Strategic consulting for product launch, pricing, contracting, patient services, evidence planning, and value communication for life sciences companies.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

The Lockwood Group is a healthcare services platform that delivers integrated medical communications, scientific animation, medical education, and market access consulting to pharmaceutical, biotech, and medical device companies. Operating through specialized subsidiaries (Lockwood Medical Communications, Random42, IDEOlogy Health, Research To Practice, Total Health, and Nexus Health), the company provides strategy, content, scientific publications, medical affairs, KOL engagement, regulatory consulting, and accredited oncology education to help life sciences clients accelerate product readiness and commercialization.

Differentiator

Problem solved

Functional benefit

Brands

• Lockwood Intelligence: AI-enabled platform offering content enhancement, insight gathering, congress coverage enhancement, literature review analysis, HCP management and engagement intelligence, landscape analysis intelligence, and community oncology intelligence.
• The AIMED Method
• The SiMPL Method
• IDEO Talks
• Sound Bites

Products and services

• Lockwood Medical Communications Medical communications agency delivering strategic scientific content, scientific publications, medical affairs solutions, and commercial marketing support. Functions as an extension of pharmaceutical, biotech, and medical device client teams to provide strategy, content, and experiences that drive better patient care outcomes.
• Random42 Scientific Animation Scientific animation studio where scientists, artists, animators, and programmers create immersive medical animations, extended reality (XR) experiences, and interactive content for scientific storytelling. Produces impactful scientific imagery, MOA/MOD animations, video abstracts, and interactive assets for pharmaceutical industry clients.
• Nexus Health Market Access Market access entity providing integrated strategic consulting, value communications, pricing and contracting, patient services, evidence planning, data insights and analytics, and policy and advocacy support. Helps manufacturers optimize product launches and commercialization with deep scientific and market access expertise.
• IDEOlogy Health Medical Education Omnichannel non-promotional medical education company providing innovative engagement platforms (IDEO Talks and Sound Bites), strategic healthcare provider communications tools, and CE-accredited medical education conferences. Reaches approximately 30% of community oncologists in the United States.
• Research To Practice (RTP) Medical education company specializing in physician and allied health professional education focused exclusively on oncology and hematology. Provides over 300 hours of accredited education across multiple formats, designed to keep cancer care clinicians current with emerging clinical data and treatment strategies.
• Total Health Oncology Education Medical information company providing free oncology medical education for cancer care professionals through tailored content, courses, and conferences delivered in-person or virtually. Delivers 60+ programs annually across virtual and in-person formats to equip clinicians with latest strategies to improve clinical practice and treatment outcomes.
• Lockwood Biotech Bespoke biotech solutions providing custom-sized teams of scientists, launch strategists, and client service experts for prelaunch, launch, and post-launch support tailored to biotechnology company needs across multiple disease states.
• Lockwood Rare Disease Specialized rare disease medical communications services partnering with companies to bring hope to patients through awareness building, advocate cultivation, patient connection, and commitment demonstration. Covers 43 rare therapeutic areas with 16 rare disease brand launches within 5 years.
• Lockwood Oncology Specialized oncology expertise with 100 dedicated scientific directors having advanced training across more than 30 tumor types and 200 years of collective experience. Offers medical strategy, communications, education, medical information, and community engagement services for oncology brands.
• Research To Practice Digital Platform Digital oncology education platform providing accredited continuing medical education (CME), Maintenance of Certification (MOC/ABIM/ABS), and Nursing Continuing Professional Development (NCPD) credits. Features 300+ hours of content, 225+ activities, single sign-on, robust search, integrated certification, and mobile-first responsive design.
• Stratis Group Commercialization Consulting Consulting firm specializing in commercialization strategy, market access, and analytics for pharmaceutical, biotechnology, and physician network clients. Adds analytics-driven commercialization expertise to the Lockwood platform.

Quantifiable outcome

• Over 100 distinct oncology brands supported in 2 dozen disease states in past 5 years
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability7 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core.

• Stratis GroupcoreStrategic or Co-development Partner · 17 March 2026Stratis Group is a consulting firm specializing in commercialization strategy, market access, and analytics for pharmaceutical, biotechnology, and physician network clients. Acquired by Nexus Health to expand commercialization and market access capabilities.
• Total HealthcoreStrategic or Co-development Partner · 23 February 2026Total Health is a leading provider of free oncology medical education for cancer care professionals. Delivers 60+ programs annually across virtual and in-person formats. Founded by Sarah Louden, Total Health expands The Lockwood Group's educational offerings.
• Research To Practice (RTP)coreStrategic or Co-development Partner · 12 November 2025Research To Practice is a medical education company based in Miami, FL, specializing in physician and allied health professional education focused exclusively on oncology and hematology. Founded by medical oncologist Neil Love, MD, with 40+ years of experience.
• IDEOlogy HealthcoreStrategic or Co-development Partner · 12 May 2025IDEOlogy Health, based in Austin TX, is a best-in-class omnichannel medical education company known for innovative engagement platforms including IDEO Talks and Sound Bites. Acquisition strengthens The Lockwood Group's community oncology presence.
• Random42coreStrategic or Co-development Partner · 2 June 2022Random42 is a scientific animation studio based in London, known for award-winning medical animations and immersive experiences. Now part of The Lockwood Group, it enhances scientific communication solutions for the pharmaceutical industry globally.

Scale indicators11 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• PRECISIONscientia: Specialized medical affairs and scientific communications agency serving pharma and biotech clients. Directly comparable to Lockwood Medical Communications on the medical affairs and publications side of Lockwood's portfolio.
• CMI/Compas: Healthcare media and communications agency focused on HCP engagement and pharma marketing. Closely aligned with Lockwood's commercial marketing, KOL engagement, and medical communications offerings.
• Fingerpaint: Independent healthcare marketing and communications agency combining advertising, medical communications, and analytics. Highly comparable to Lockwood's integrated communications and commercialization positioning.
• MedThink Communications: Medical communications and healthcare marketing agency with strong promotional and non-promotional capabilities. Directly comparable across Lockwood's medical affairs and commercial marketing segments.
• Trinity Life Sciences: Life sciences strategic consulting firm specializing in market access, commercialization, and evidence generation. Closely comparable to Nexus Health and Stratis Group within the Lockwood platform.

Broad incumbents

• Havas Health & You: Global healthcare communications network within Havas offering brand, medical, and digital communications across pharma. Wider portfolio than Lockwood but overlapping medical communications capabilities.
• Publicis Health: Global healthcare communications network within Publicis offering medical affairs, advertising, and patient engagement. Competes with Lockwood across medical communications with broader scale.
• Omnicom Health Group: Healthcare communications holding group within Omnicom offering medical education, advertising, and PR. Competes with Lockwood across the medical communications value chain with broader service breadth.
• Syneos Health: Large biopharmaceutical services organization combining clinical development and commercialization services. Overlaps with Lockwood's market access and medical communications segments as part of a broader CRO offering.

Emerging players

• Real Chemistry: Healthcare marketing and communications firm combining data, creative, and media capabilities. Comparable to Lockwood's integrated communications and analytics-driven engagement offerings with a more digital-native orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/thelockwoodgrp
• YouTubeyoutube.com/user/Random42Medical
• Facebookfacebook.com/The-Lockwood-Group-253339792070255
• LinkedInlinkedin.com/company/the-lockwood-group
• Instagraminstagram.com/random42scientific

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Lockwood Group